Curative Efficacy of Nimodipine combined with Latanoprost in Treatment of Primary Open-angle Glaucoma and Effects on the Aqueous Humor EPO ET-1 sCD44 Level
LIU Shuang, KONG Fanhong, et al
Luhe Hospital Affiliated to Capital Medical University, Beijing 101100, China
Abstract：Objective: To study the curative efficacy of nimodipine combined with latanoprost in treatment of primary open-angle glaucoma and effects on the aqueous humor erythropoietin(EPO), endothelin-1(ET-1), soluble CD44(sCD44) levels. Methods: 91 patients of primary open-angle glaucoma who received therapy from June 2015 to June 2017 in our hospital were selected as research objects, according to the random number table, those patients were divided into the 46 cases of observation group and the 45 cases of control group. The control group was treated with latanoprost, while the observation group was treated with nimodipine on the basis of the control group, they were continuous treatment for 6 months. The clinical efficacy, the changes of visual related index, optic disc sieve plate blood flow, aqueous humor EPO, ET-1, sCD44 levels and adverse reactions were compared between the two groups. Results: After treatment, the total effective rate of the observation group was 93.48% (43/46), which was significantly higher than that of the control group 77.78% (35/45) (P<0.05). The intraocular pressure and visual field defect in the observation group were significantly lower than that of the control group [(16.57±1.54)mmHg vs(18.72±1.85)mmHg,(9.21±1.10)dB vs(11.37±1.20)dB], the retinal light sensitivity and visual acuity were significantly higher than that of the control group[(18.74±2.30)dB vs(16.89±2.03)dB,(0.76±0.12)vs(0.71±0.09)](P<0.05). In the optic disc sieve plate blood flow, the blood flow velocity, blood flow and erythrocyte mobility in the observation group were significantly higher than that of the control group [(188.42±20.56)mm/s vs(167.34±17.57)mm/s,(15.68±1.62)L/min vs(12.73±1.50)L/min,(1.04±0.15)vs(0.83±0.10)](P<0.05); and the aqueous humor EPO, ET-1, sCD44 levels in the observation group were significantly lower than that of the control group [(7.05±1.17)mU/ml vs (8.49±1.45)mU/ml,(43.72±4.59)ng/L vs(51.04±5.64)ng/L,(13.40±1.39)ng/ml vs(18.15±1.70)ng/ml](P<0.05). During the treatment, the incidence of adverse reactions in the two groups was 10.87% (5/46) and 8.89% (4/45) respectively, and the difference was not statistically significant (P>0.05). Conclusion: The effect of nimodipine combined with latanoprostaglandin in patients with primary open angle glaucoma is remarkable. Its intrinsic mechanism may be related to the reduction of EPO, ET-1 and sCD44 expression in aqueous humor. Moreover, the safety of nimodipine combined with latanoprostaglandin is high, and it is worth popularizing.
刘爽, 孔凡宏, 施歌. 尼莫地平联合拉坦前列腺素治疗原发性开角型青光眼的疗效及对房水EPO ET-1 sCD44的影响[J]. 河北医学, 2019, 25(1): 25-29.
LIU Shuang, KONG Fanhong, et al. Curative Efficacy of Nimodipine combined with Latanoprost in Treatment of Primary Open-angle Glaucoma and Effects on the Aqueous Humor EPO ET-1 sCD44 Level. HeBei Med, 2019, 25(1): 25-29.
[1] 陈强,李丹慧,江新泉,等.中国原发性开角型青光眼患病率meta分析[J].中国公共卫生,2016,32(9):1271~1275. [2] Ahoor MH, Ghorbanihaghjo A, Sorkhabi R, et al. Klotho and endothelin-1 in pseudoexfoliation syndrome and glaucoma[J].Glaucoma, 2016, 25(12): 919~922. [3] Shirley Ding SL, Leow SN, et al. Revisiting the role of erythropoietin for treatment of ocular disorders[J]. Eye (Lond), 2016, 30(10): 1293~1309. [4] Tong J, Li J, Zhang QS, Yang JK, et al. Delayed cognitive deficits can be alleviated by calcium antagonist nimodipine by downregulation of apoptosis following whole brain radiotherapy[J]. Oncol Lett, 2018, 16(2): 2525~2532. [5] 李素美.尼莫地平对青光眼视网膜神经节细胞的保护作用及机制[J].中国实用神经疾病杂志,2014,17(22):114~115. [6] 任霞,贺经,冯延琴.原发性开角型青光眼治疗进展[J].国际眼科杂志,2016,16(3):458~461. [7] Aktas Z, Unlu M, Uludag K, Erten Y, et al. The effect of systemic erythropoietin treatment on retinal nerve fiber layer parameters in patients with chronic renal failure undergoing peritoneal dialysis[J].Glaucoma, 2015, 24(3): 214~218. [8] Gugleta K. Significance of endothelin-1 in glaucoma - a short overview[J]. Klin Monbl Augenheilkd, 2018, 235(2): 140~145. [9] 刘思彤,吴志鸿.原发性开角型青光眼视网膜纤维层厚度、视野缺损与房水中sCD44浓度的相关性研究[J].中华灾害救援医学,2018,6(1):19~23. [10] Sun J, Zheng J, Wang F, et al. Effect of hyperbaric oxygen combined with nimodipine on treatment of diffuse brain injury[J]. Exp Ther Med, 2018, 15(6):4 651~4658. [11] Maria DN, Abd-Elgawad AH, Soliman OA, et al. Nimodipine ophthalmic formulations for mManagement of glaucoma[J]. Pharm Res, 2017, 34(4): 809~824. [12] 刘国谈.尼莫地平治疗原发性开角型青光眼的临床疗效分析[J].中国实用医药,2015,10(17):148~149.
2019, Vol. 25 
冀公网安备13080202000786号